FDA Issues CBD Warnings and Alerts of Possible Side Effects
The Food and Drug Administration (FDA) yesterday issued 15 warning letters to cannabidiol (CBD) companies and updated its advice for consumers to follow while regulations are developed. Citing numerous safety concerns and a lack of scientific information, FDA said it cannot recognize CBD as generally recognized as safe (GRAS) for use in human or animal food.